Cargando…

Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?

Sarcomas are a group of diverse and complex cancers of mesenchymal origin that remains poorly understood. Recent developments in cancer immunotherapy have demonstrated a potential for better outcomes with immune checkpoint inhibition in some sarcomas compared to conventional chemotherapy. Immune che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiong, Chin Sern, Lin, Tzu Ping, Lim, Vivian Yujing, Toh, Tan Boon, Yang, Valerie Shiwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463641/ https://www.ncbi.nlm.nih.gov/pubmed/37612756 http://dx.doi.org/10.1186/s40364-023-00513-5

Ejemplares similares

MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas
por: Teo, Andrea York Tiang, et al.
Publicado: (2023)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

Biomarkers in psychiatry: how close are we?
por: Kobeissy, Firas, et al.
Publicado: (2013)

Quantitative Image-Based Cell Viability (QuantICV) Assay for Microfluidic 3D Tissue Culture Applications
por: Ong, Louis Jun Ye, et al.
Publicado: (2020)

Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives
por: Tang, Swee Ping, et al.
Publicado: (2021)

Advances in immune checkpoint inhibitors for bone sarcoma therapy
por: Thanindratarn, Pichaya, et al.
Publicado: (2019)

Immune checkpoint inhibitor resistance in soft tissue sarcoma
por: Eulo, Vanessa, et al.
Publicado: (2022)

Are we over-treating with checkpoint inhibitors?
por: Danson, Sarah, et al.
Publicado: (2019)

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
por: Rizzo, Alessandro, et al.
Publicado: (2021)

The electrocardiogram for sepsis: how close are we?
por: Levy, Mitchell M
Publicado: (2007)

Big data in healthcare: are we close to it?
por: Naidus, Elliot, et al.
Publicado: (2016)

Malaria therapeutics: are we close enough?
por: Tripathi, Himani, et al.
Publicado: (2023)

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021)

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
por: Siozopoulou, Vasiliki, et al.
Publicado: (2021)

Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
por: Helbig, Doris, et al.
Publicado: (2022)

The Physiologic Basis and Clinical Outcomes of Combined Impella and Veno-Arterial Extracorporeal Membrane Oxygenation Support in Cardiogenic Shock
por: Lim, Hoong Sern
Publicado: (2020)

Phenotyping and Hemodynamic Assessment in Cardiogenic Shock: From Physiology to Clinical Application
por: Lim, Hoong Sern
Publicado: (2022)

Sarcoma Stem Cells: Do We Know What We Are Looking for?
por: Trucco, Matteo, et al.
Publicado: (2012)

BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis
por: Yang, Dinglong, et al.
Publicado: (2021)

Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012)

Rabies Treatment: Are We Anywhere Close to Cure?
por: Senthilkumaran, Subramanian, et al.
Publicado: (2018)

How close are we to therapies for Sanfilippo disease?
por: Gaffke, Lidia, et al.
Publicado: (2017)

Physician density: will we ever close the gap?
por: Ferretti, Fabrizio, et al.
Publicado: (2023)

Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017)

Delaying the final cut: A close encounter of checkpoint kinases at the midbody
por: Hadders, Michael A., et al.
Publicado: (2021)

Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
por: Sundar, Raghav, et al.
Publicado: (2020)

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas
por: Dancsok, Amanda R., et al.
Publicado: (2020)

RIPK3 modulates sarcoma through immune checkpoint HAVCR2
por: Qian, Chen, et al.
Publicado: (2022)

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
por: Anzar, Irantzu, et al.
Publicado: (2023)

Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)

Metastatic biomarkers in synovial sarcoma
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2017)

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
por: Tay, Sen Hee, et al.
Publicado: (2022)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Closing Yield Gaps: How Sustainable Can We Be?
por: Pradhan, Prajal, et al.
Publicado: (2015)

Should we close small ventricular septal defects?
por: Viswanathan, Sangeetha, et al.
Publicado: (2017)

Vaccines for Perinatal and Congenital Infections—How Close Are We?
por: Singh, Tulika, et al.
Publicado: (2020)

World Hepatitis Day 2023: Are we close to the target?
por: Hui, Rex Wan-Hin, et al.
Publicado: (2023)

Molecular Screening for Urothelial Cancer: How Close We Are?
por: Michas, Athanasios, et al.
Publicado: (2023)

Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are
por: Saggioro, Mattia, et al.
Publicado: (2020)

The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets
por: Tan, Linyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_unfleb9u3nas5tg21i31ja57ok